Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
In this article
Eli Lilly
and Walmart
on Wednesday said they have teamed up to expand access to the drugmaker’s weight loss drug Zepbound, allowing U.S. patients to get vials of the blockbuster injection at direct-to-consumer prices through retail locations for the first time.
The announcement comes as Eli Lilly works to maintain its dominance over rival Novo Nordisk
The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs…
Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's…
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand access.
Reducing the dose of Eli Lilly’s obesity shot Zepbound could provide a safe, effective and potentially cheaper option for the…
The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound…
